SEC Company Response from AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Sep 28, 2017
AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: Sept. 28, 2017 · CIK: 0001460702 · Accession: 0001493152-17-011001
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-219147
Letter
AEGIS CAPITAL CORP.
Seventh Avenue
New York, New York 10019
September 28, 2017
VIA EDGAR
U.S. Securities and Exchange Commission
F St., NE
Washington D.C. 20549
Attention: Tim Buckmiller
Re: Ritter Pharmaceuticals, Inc.
Registration Statement on Form S-1 (File No. 333-219147)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Aegis Capital Corp., as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on September 28, 2017, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
AEGIS
CAPITAL CORP.
Show Raw Text
CORRESP
1
filename1.htm
AEGIS
CAPITAL CORP.
810
Seventh Avenue
New
York, New York 10019
September
28, 2017
VIA
EDGAR
U.S.
Securities and Exchange Commission
100
F St., NE
Washington
D.C. 20549
Attention:
Tim Buckmiller
Re:
Ritter Pharmaceuticals, Inc.
Registration
Statement on Form S-1 (File No. 333-219147)
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Aegis Capital Corp., as representative of the underwriters, hereby requests acceleration of the effective date of
the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on September 28, 2017,
or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is
reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form
of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary
prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
AEGIS
CAPITAL CORP.
By:
/s/
Tom Higgins
Tom
Higgins
Vice
President, Investment Banking